Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations
2007

Treatment Recommendations for Brucellosis

publication Evidence: moderate

Author Information

Author(s): Javier Ariza, Mile Bosilkovski, Antonio Cascio, Juan D. Colmenero, Michael J. Corbel, Matthew E. Falagas, Ziad A. Memish, Mohammad Reza Hasanjani Roushan, Ethan Rubinstein, Nikolaos V. Sipsas, Javier Solera, Edward J. Young, Georgios Pappas

Hypothesis

What is the optimal treatment regimen for human brucellosis?

Conclusion

The study provides evidence-based recommendations for treating brucellosis, emphasizing the need for a combination of doxycycline with either streptomycin or rifampicin.

Supporting Evidence

  • Brucellosis is the most common anthropozoonotic infection worldwide.
  • The WHO recommended regimens for brucellosis treatment have not been universally applied.
  • Relapses occur in 5% to 15% of uncomplicated cases, indicating the need for effective treatment strategies.
  • Prolonged treatment reduces the risk of relapse.
  • Emerging antimicrobial resistance poses challenges for treatment in endemic regions.

Takeaway

Brucellosis is a common infection that needs careful treatment with specific antibiotics to avoid relapses.

Methodology

The authors reviewed existing literature and conducted a consensus meeting to develop treatment recommendations.

Potential Biases

Potential biases may arise from the authors' affiliations and the selection of studies reviewed.

Limitations

The recommendations are based on existing studies, which may have varying quality and design.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0040317

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication